Intellipharmaceutics International Inc.
IPCIQ
$0.00
$0.000.00%
OTC PK
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.17M | -1.58M | -2.37M | -2.89M | -3.97M |
| Total Depreciation and Amortization | 187.30K | 198.20K | 209.20K | 220.10K | 218.30K |
| Total Amortization of Deferred Charges | -13.80K | -13.80K | -13.80K | -14.00K | 1.60K |
| Total Other Non-Cash Items | 511.10K | 497.90K | 37.10K | -47.30K | 123.00K |
| Change in Net Operating Assets | 2.61M | 484.80K | 1.29M | 1.35M | 2.10M |
| Cash from Operations | 120.40K | -413.50K | -841.80K | -1.39M | -1.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 500.00K | 500.00K | 500.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 500.00K | 500.00K | 500.00K |
| Total Debt Issued | 200.00K | 200.00K | 200.00K | 200.00K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 200.00K | 200.00K | 200.00K | 200.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 320.40K | -213.50K | -141.80K | -688.20K | -1.03M |